Effect of OPRM1/COMT gene polymorphisms on sufentanil labor analgesia: a cohort study based on propensity score matching

Pharmacogenomics. 2023 Aug;24(12):675-684. doi: 10.2217/pgs-2023-0103. Epub 2023 Aug 23.

Abstract

Background: This study investigated the use of COMT G1947A and OPRM1 A118G polymorphisms as predictive markers for sufentanil epidural analgesia. Methods: The visual analogue scale (VAS) score, and sufentanil consumption of 136 pairs of parturients using sufentanil with lidocaine and ropivacaine for epidural analgesia were used for analysis. Results: OPRM1 AG/GG had lower VAS score difference between fifth and 0 min (1.55 vs 1.87; p = 0.012) and higher consumption (19.65 μg vs 17.11 μg; p = 0.049) than AA carriers. COMT GA/AA had higher VAS score difference than GG carriers (1.86 vs 1.55; p = 0.021). Conclusion: Sufentanil may provide better epidural labor analgesia in OPRM1 AA and COMT GA/AA carriers compared with OPRM1 AG/GG and COMT GG carriers. Clinical Trial Registration: ChiCTR1900026897 (Chinese Clinical Trial Center Registry).

Keywords: COMT; OPRM1; analgesia; labor; sufentanil.

MeSH terms

  • Analgesia, Epidural*
  • Analgesics
  • Analgesics, Opioid / adverse effects
  • Catechol O-Methyltransferase / genetics
  • Cohort Studies
  • Double-Blind Method
  • Female
  • Humans
  • Polymorphism, Genetic
  • Pregnancy
  • Propensity Score
  • Receptors, Opioid, mu / genetics
  • Sufentanil* / therapeutic use

Substances

  • Analgesics
  • Analgesics, Opioid
  • Catechol O-Methyltransferase
  • COMT protein, human
  • OPRM1 protein, human
  • Receptors, Opioid, mu
  • Sufentanil